US Stock Insider Trading | Ingevity disclosed one insider trading transaction on March 2

robot
Abstract generation in progress

On March 2, 2026, Ingevity (NGVT) disclosed one insider transaction. Executive Clontz Clarence Reid Jr. sold 69 shares on February 26, 2026.

[Recent Insider Transactions]

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
March 2, 2026 Executive Clontz Clarence Reid Jr. February 26, 2026 Sell 69 70.52 4,865.88
January 6, 2026 Director Segal Francis David, WILLIS J KEVIN January 2, 2026 Buy 875 60.09 $52,600
October 6, 2025 Director FERNANDEZ-MORENO LUIS M October 2, 2025 Sell 6,004 56.31 $338,100
October 2, 2025 Director Segal Francis David, WILLIS J KEVIN October 1, 2025 Buy 920 54.44 $50,100
July 9, 2025 Executive Fisher Ryan C. July 7, 2025 Sell 169 45.34 $7,662.46
July 3, 2025 Director Segal Francis David, WILLIS J KEVIN July 1, 2025 Buy 1,127 44.40 $50,000
May 5, 2025 Director Segal Francis David, WILLIS J KEVIN May 1, 2025 Buy 828 33.28 $27,600
April 2, 2025 Director WILLIS J KEVIN April 1, 2025 Buy 580 38.85 $22,500
March 26, 2025 Executive Fisher Ryan C. March 25, 2025 Sell 310 43.07 $13,400
March 4, 2025 Executive Fisher Ryan C. February 28, 2025 Sell 753 47.66 $35,900

[Company Information]

Ingevity Corporation was incorporated on March 27, 2015, in Delaware. Ingevity is a global leader in specialty chemicals and high-performance carbon materials. The company provides innovative solutions through proprietary formulation products to meet the unique and demanding requirements of its customers. With deep technical expertise and experience, flexible manufacturing, unique chemistry, global reach, and a focus on innovation and application development, Ingevity helps its customers enhance their products and competitive position in the markets they serve.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin